An increasing number of states offer medical cannabis programs. In most cases, to be eligible, patients must be diagnosed with a specific condition listed by the state. Unfortunately, the list of qualifying conditions can be very limited, meaning a large number of people with chronic pain are left without access.

On July 17, the Hartford Courant published an op-ed by Ellen Lenox Smith–U.S. Pain Foundation board member and Medical Cannabis Co-Director–about Connecticut’s recent refusal to add chronic pain as a qualifying condition for medical cannabis.

“This decision to not include “chronic pain” as a qualifying condition is damaging to so many. I never wish ill will on others, but I do have to wonder — if they ended up with a rare condition, would they also feel like me, like they were being left in the dust and not of value?” wrote Lenox Smith, who lives with Ehlers-Danlos syndrome and sarcoidosis.

To read the op-ed, click here.

To learn more about our Medical Cannabis program, click here.